Padcev (Enfortumab Vedotin)

Enfortumab vedotin, the active ingredient in Padcev, is a antibody‑drug conjugate presented as a sterile powder for intravenous infusion use. It treats adult patients with locally advanced or metastatic uro‑urinary tract cancer who have received prior PD‑1 or PD‑L1 inhibitor therapy. GNH USA supplies Padcev as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Padcev as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Padcev is an antibody‑drug conjugate that targets N‑N‑dimethyl‑t‑    

Common